RD
Therapeutic Areas
Interna TX Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MNM‑siRNA COVID‑19 | SARS‑CoV‑2 infection (COVID‑19) | Phase 1 |
| MNM‑siRNA RSV | Respiratory syncytial virus | Preclinical |
| MNM‑siRNA IPF | Idiopathic pulmonary fibrosis | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| MNM‑siRNA COVID‑19 | SARS‑CoV‑2 infection (COVID‑19) | Phase 1 |
| MNM‑siRNA RSV | Respiratory syncytial virus | Preclinical |
| MNM‑siRNA IPF | Idiopathic pulmonary fibrosis | Preclinical |